Navigation Links
Liquichek Unassayed Chemistry Control (Human)

ProductsLiquichek Unassayed Chemistry Control (Human)
Company Bio-Rad Laboratories
Item Liquichek Unassayed Chemistry Control (Human)
Features 
  • Liquid, human serum based
  • 2 year shelf life at -10 to -20C
  • 15 day open-vial stability at 2-8C
  • Elevated cholesterol
  • Commutability across most major chemistry instruments
  • No glycols or organic solvents added
Description Liquichek Unassayed Chemistry Control (Human) is a comprehensive, stable, liquid product designed to monitor general and special chemistry tests.
Info Bio-Rad Laboratories
Customer Service: 1-800-2-BIORAD
Web site: http://www.bio-rad.com

Related medicine products :

1. Liquichek Rheumatoid Factor Control
2. Liquichek Immunology Control
3. Liquichek Immunoassay Plus Control
4. Liquichek Spinal Fluid Control
5. Liquichek Urine Chemistry Control
6. Liquichek Whole Blood Volatiles Control
7. Liquichek Urinalysis Control
8. Liquichek Serum Volatiles Control
9. Liquichek Therapeutic Drug Monitoring Control (TDM)
10. Liquichek Autoimmune Controls - ANA
11. Liquichek Pediatric Control
... Durable ergonomic chairs with concave seats ... • Select options like seats, backrests, ... Choose the BE Series for top ... including: industry, education, laboratory, clean room, ...
... with concave seats and large backrests with ... backrests, armrests, and casters and glides. • ... in a variety of environments including: industry, ... care and office. • With cast aluminum ...
... Durable ergonomic chairs with concave seats ... • Select options like seats, backrests, ... Choose the BE Series for top ... including: industry, education, laboratory, clean room, ...
... with concave seats and large backrests ... like seats, backrests, armrests, and casters ... Series for top performance in a ... laboratory, clean room, static control, health ...
Medicine Products:
(Date:2/8/2016)... , ... February 08, 2016 , ... ... co-occur frequently. While a significant number of women and men with eating disorders ... trauma itself, that best predicts the development of an eating disorder. , ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... than 50% lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort ... is time to make a change in public health,” states Carole Baggerly, Director ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... will be speaking on how healthcare companies can use newly released government data ... health of a population and intervene and capture the value they create to ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... (NADL), only four states in the U.S. require dental technicians to be certified ... in the dental industry, NADL created the “What’s In Your Mouth?” campaign to ...
(Date:2/7/2016)... (PRWEB) , ... February 07, 2016 , ... ... MyDecision™ program. MyDecision™ empowers employers and organizations with the tools and information to ... combines three elements to cut the cost of providing employee healthcare benefits by ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, ... therapeutic genome editing, announced that the U.S. Food ... Investigational New Drug (IND) application for SB-318, a ... therapy for Mucopolysaccharidosis Type I (MPS I). The ... Sangamo to initiate a Phase 1/2 clinical study ...
(Date:2/8/2016)... 8, 2016  CTI BioPharma Corp. (CTI BioPharma) (NASDAQ ... communication from the U.S. Food and Drug Administration (FDA) ... a partial clinical hold on the clinical studies being ... for pacritinib. This clinical hold impacts part of the ... will also affect planned clinical trials. ...
(Date:2/5/2016)... Amgen (NASDAQ: AMGN ) will present at ... at 9:15 a.m. ET on Wednesday, Feb. 10, 2016, in ... Meline , executive vice president and chief financial officer at ... presentation can be accessed from the Events Calendar on Amgen,s ... webcast will also be available on Amgen,s website for at ...
Breaking Medicine Technology: